BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MGI PHARMA, INC. (MOGN): Notice of Conversion Right for Senior Subordinated Convertible Notes Due 2024


12/27/2007 9:47:22 AM

BLOOMINGTON, Minn.--(BUSINESS WIRE)--MGI PHARMA, INC. (NASDAQ:MOGN) (the “Company” or “MGI PHARMA”), today announced that the Company’s Senior Subordinated Convertible Notes due 2024 (the “Notes”) shall become convertible as a result of the Company entering into an Agreement and Plan of Merger (the “Merger Agreement”), dated December 10, 2007, with Eisai Co., Ltd. (“Eisai”) and Jaguar Acquisition Corp. (“Purchaser”) pursuant to which it is anticipated that all of the Company’s outstanding shares of common stock (other than shares of common stock held by Eisai or its subsidiaries or by stockholders who have validly exercised their dissenters’ rights under Minnesota law), will be acquired by Purchaser at a cash purchase price of $41.00 per share pursuant to a tender offer (the “Offer”) followed by a “second-step” merger (the “Merger”).

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES